| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JNCI/DJS288 |
| P698 | PubMed publication ID | 22781434 |
| P50 | author | Robert G. Bristow | Q42414379 |
| Steven A. Narod | Q50384888 | ||
| John Trachtenberg | Q122735342 | ||
| P2093 | author name string | Robert K Nam | |
| Justin Lee | |||
| Andrew Loblaw | |||
| Mohammad R Akbari | |||
| Stephanie Tam | |||
| P433 | issue | 16 | |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 1260-1262 | |
| P577 | publication date | 2012-07-09 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Association between germline HOXB13 G84E mutation and risk of prostate cancer | |
| P478 | volume | 104 |
| Q46000370 | A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding. |
| Q98947294 | ACK1-AR and AR-HOXB13 signaling axes: epigenetic regulation of lethal prostate cancers |
| Q37375359 | Aberrant expression of posterior HOX genes in well differentiated histotypes of thyroid cancers |
| Q26740628 | Advances in genetics: widening our understanding of prostate cancer |
| Q37687127 | Association between germline homeobox B13 (HOXB13) G84E allele and prostate cancer susceptibility: a meta-analysis and trial sequential analysis |
| Q50480505 | Contribution of Caudal Müllerian Duct Mesenchyme to Prostate Development. |
| Q44532070 | Familial prostate cancer and HOXB13 founder mutations: geographic and racial/ethnic variations |
| Q45369342 | G84E mutation in HOXB13 is firmly associated with prostate cancer risk: a meta-analysis |
| Q35827235 | Germline HOXB13 p.Gly84Glu mutation and cancer susceptibility: a pooled analysis of 25 epidemiological studies with 145,257 participates |
| Q57265601 | Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer |
| Q37161398 | Germline missense variants in the BTNL2 gene are associated with prostate cancer susceptibility |
| Q37705596 | HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey |
| Q35955313 | HOXB13 and ALX4 induce SLUG expression for the promotion of EMT and cell invasion in ovarian cancer cells |
| Q36741627 | HOXB13 mutation and prostate cancer: studies of siblings and aggressive disease |
| Q38629410 | HOXB13 mutations and binding partners in prostate development and cancer: Function, clinical significance, and future directions |
| Q36728798 | HOXB13 mutations in a population-based, case-control study of prostate cancer |
| Q64074106 | Homeobox B13 G84E Mutation and Prostate Cancer Risk |
| Q38163195 | Human HOX gene disorders. |
| Q35855122 | Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients |
| Q34502671 | Identification of a novel germline SPOP mutation in a family with hereditary prostate cancer |
| Q47151248 | Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours. |
| Q28386845 | Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort |
| Q55249860 | Male Oncology Research and Education program for men at high risk for prostate cancer. |
| Q38723089 | Oncogenic mechanisms of HOXB13 missense mutations in prostate carcinogenesis. |
| Q64940824 | Paralogous HOX13 Genes in Human Cancers. |
| Q99408702 | Pathogenic Germline DNA Repair Gene and HOXB13 Mutations in Men With Metastatic Prostate Cancer |
| Q34606248 | Population-based estimate of prostate cancer risk for carriers of the HOXB13 missense mutation G84E. |
| Q37356530 | Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer |
| Q33639057 | Prevalence of the HOXB13 G84E mutation among unaffected men with a family history of prostate cancer |
| Q37698968 | Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy |
| Q38967495 | Prostate Cancer Genetics: A Review |
| Q37085446 | Prostate cancer risk-associated genetic markers and their potential clinical utility |
| Q46083971 | Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. |
| Q38967389 | Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers |
| Q91638141 | Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer |
| Q36895390 | The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial |
| Q36029481 | The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies |
| Q36438352 | The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer |
| Q38203985 | The epidemiology and clinical implications of genetic variation in prostate cancer |
| Q40625913 | The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer |
Search more.